Interpace Biosciences Inc (IDXG)
3.09
-0.19
(-5.79%)
USD |
OTCM |
Nov 14, 15:46
Interpace Biosciences Profit Margin (Quarterly): 17.12% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.12% |
| March 31, 2024 | 4.56% |
| December 31, 2023 | 8.66% |
| September 30, 2023 | -6.76% |
| June 30, 2023 | 1.59% |
| March 31, 2023 | 3.57% |
| December 31, 2022 | -18.77% |
| September 30, 2022 | -173.5% |
| June 30, 2022 | -53.27% |
| March 31, 2022 | -28.36% |
| December 31, 2021 | -40.93% |
| September 30, 2021 | -44.20% |
| June 30, 2021 | -30.89% |
| March 31, 2021 | -42.78% |
| December 31, 2020 | -84.42% |
| September 30, 2020 | -75.58% |
| June 30, 2020 | -102.5% |
| March 31, 2020 | -71.69% |
| December 31, 2019 | -253.0% |
| September 30, 2019 | -96.39% |
| June 30, 2019 | -84.59% |
| March 31, 2019 | -55.34% |
| December 31, 2018 | -78.01% |
| September 30, 2018 | -52.88% |
| June 30, 2018 | -34.85% |
| Date | Value |
|---|---|
| March 31, 2018 | -66.40% |
| December 31, 2017 | -114.6% |
| September 30, 2017 | -78.91% |
| June 30, 2017 | -163.6% |
| March 31, 2017 | 69.57% |
| December 31, 2016 | |
| September 30, 2016 | -226.0% |
| June 30, 2016 | -64.62% |
| March 31, 2016 | -157.7% |
| December 31, 2015 | |
| September 30, 2015 | -195.3% |
| June 30, 2015 | -309.7% |
| March 31, 2015 | -182.7% |
| December 31, 2014 | 8.33% |
| September 30, 2014 | -15.34% |
| June 30, 2014 | -8.57% |
| March 31, 2014 | -5.06% |
| December 31, 2013 | -11.42% |
| September 30, 2013 | -6.25% |
| June 30, 2013 | -2.37% |
| March 31, 2013 | 4.95% |
| December 31, 2012 | -66.78% |
| September 30, 2012 | -3.21% |
| June 30, 2012 | -1.58% |
| March 31, 2012 | -0.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-253.0%
Minimum
Dec 2019
17.12%
Maximum
Jun 2024
-52.16%
Average
-40.93%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 3.20% |
| XWELL Inc | -21.50% |
| ProPhase Labs Inc | -248.7% |
| Applied DNA Sciences Inc | -- |
| Veracyte Inc | 13.08% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 20.53% |
| Gross Profit Margin (Quarterly) | 61.71% |
| Operating Margin (Quarterly) | 18.74% |
| Return on Net Operating Assets | 28.66% |